CIK 0001937653 · Non-accelerated filer<br>Smaller reporting company
Zymeworks Inc.
Sign in to watch- Ticker
- ZYME
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 883099146
- Phone
- 302-274-8744
- Business address
- 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
- Former names
- Zymeworks Delaware Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $357,557
- in 1 filing
Net −$357,557. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-12 | Hollywood Mark EVP & Chief Operating Officer | Grant or award · Performance Stock Unit | +66,000 | 66,000 | ||
| 2026-01-12 | Cherry Brian N Director | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2026-01-12 | Cherry Brian N Director | Grant or award · Restricted Stock Unit | +15,400 | 15,400 | ||
| 2026-01-12 | Smith Jeffrey T L EVP & Chief Medical Officer | Option exercise | +17,666 | 36,018 | ||
| 2026-01-12 | Smith Jeffrey T L EVP & Chief Medical Officer | Sale | −9,310 | $22.67 | $211K | 26,708 |
| 2026-01-12 | Smith Jeffrey T L EVP & Chief Medical Officer | Option exercise · Restricted Stock Unit | −17,666 | 35,334 | ||
| 2026-01-12 | Ciongoli Gregory Austin Director | Grant or award · Stock Option (Right to Buy) | +11,500 | 11,500 | ||
| 2026-01-12 | Ciongoli Gregory Austin Director | Grant or award · Restricted Stock Unit | +7,700 | 7,700 | ||
| 2026-01-12 | Neu Kelvin Director | Grant or award · Stock Option (Right to Buy) | +11,500 | 11,500 | ||
| 2026-01-12 | Neu Kelvin Director | Grant or award · Restricted Stock Unit | +7,700 | 7,700 | ||
| 2026-01-12 | Landry Robert E Director | Grant or award · Stock Option (Right to Buy) | +11,500 | 11,500 | ||
| 2026-01-12 | Landry Robert E Director | Grant or award · Restricted Stock Unit | +7,700 | 7,700 | ||
| 2026-01-12 | Cesano Alessandra Director | Grant or award · Stock Option (Right to Buy) | +11,500 | 11,500 | ||
| 2026-01-12 | Cesano Alessandra Director | Grant or award · Restricted Stock Unit | +7,700 | 7,700 | ||
| 2026-01-12 | Campoy Carlos Director | Grant or award · Stock Option (Right to Buy) | +11,500 | 11,500 | ||
| 2026-01-12 | Campoy Carlos Director | Grant or award · Restricted Stock Unit | +7,700 | 7,700 | ||
| 2026-01-12 | Mahony Susan Director | Grant or award · Stock Option (Right to Buy) | +11,500 | 11,500 | ||
| 2026-01-12 | Mahony Susan Director | Grant or award · Restricted Stock Unit | +7,700 | 7,700 | ||
| 2026-01-12 | Moore Paul Andrew Chief Scientific Officer | Option exercise | +17,666 | 58,057 | ||
| 2026-01-12 | Moore Paul Andrew Chief Scientific Officer | Sale | −9,560 | $22.67 | $217K | 48,497 |
Page 2 of 12 · 224 trades